Knihovna AV ČR, v. v. i.
  • Odhlásit
  • Přihlášení
  • Jazyk
    • English
    • Čeština
  • Instituce
    • Knihovna AV ČR
    • Souborný katalog AV ČR
    • Archeologický ústav Brno
    • Archeologický ústav Praha
    • Astronomický ústav
    • Biofyzikální ústav
    • Botanický ústav
    • Etnologický ústav
    • Filosofický ústav
    • Fyzikální ústav
    • Fyziologický ústav
    • Geofyzikální ústav
    • Geologický ústav
    • Historický ústav
    • Masarykův ústav
    • Matematický ústav
    • Orientální ústav
    • Psychologický ústav
    • Slovanský ústav
    • Sociologický ústav
    • Ústav analytické chemie
    • Ústav anorganické chemie
    • Ústav pro českou literaturu
    • Ústav dějin umění
    • Ústav fyziky atmosféry
    • Ústav fotoniky a elektroniky
    • Ústav fyzikální chemie J. H.
    • Ústav fyziky materiálů
    • Ústav geoniky
    • Ústav pro hydrodynamiku
    • Ústav chemických procesů
    • Ústav informatiky
    • Ústav pro jazyk český
    • Ústav jaderné fyziky
    • Ústav makromolekulární chemie
    • Ústav pro soudobé dějiny
    • Ústav přístrojové techniky
    • Ústav státu a práva
    • Ústav struktury a mechaniky hornin
    • Ústav teoretické a aplikované mechaniky
    • Ústav teorie informace a automatizace
    • Ústav výzkumu globální změny
Pokročilé vyhledávání
  • Domovská stránka
  • Vyhledávání: "Jh, Bourhis"
  • Navrhnout nákup titulu
Zobrazeno 1 - 10 of 218 pro vyhledávání: '"Jh, Bourhis"'
1
Myeloid and lymphoid chimerism after T-cell-depleted bone marrow transplantation: evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA
Autor: P Black, L. Barnett, G. Heller, R.J. O'Reilly, JH Bourhis, Stephen Mackinnon
Publikováno v: Blood. 80:3235-3241
Determining both myeloid and lymphoid chimerism after T-cell-depleted allogeneic bone marrow transplantation (BMT) could be helpful in the understanding of the biology of engraftment and could provide a rational method of assessing the ability of dif
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1602899f1061bfb5e1ffa3a8c78f2e91
https://doi.org/10.1182/blood.v80.12.3235.bloodjournal80123235
Zobrazit plný text záznamu
2
Clonal analysis of myelodysplastic syndrome: monosomy 7 is expressed in the myeloid lineage, but not in the lymphoid lineage as detected by fluorescent in situ hybridization
Autor: JH Bourhis, R.J. O'Reilly, John F. Donohue, Hugo Castro-Malaspina, J Bauman, Nancy A. Kernan, WR Gerritsen, Suresh C. Jhanwar
Publikováno v: Blood. 80:217-224
Conflicting results have been published on whether or not myelodysplastic syndromes (MDS) affect all cell lineages. Involvement of myeloid and erythroid cell lineages has been regularly observed, but it remains controversial whether the different lym
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2c67bb86137fa142902c728114f5359
https://doi.org/10.1182/blood.v80.1.217.bloodjournal801217
Zobrazit plný text záznamu
3
Comparison of autologous bone marrow transplantation and peripheral blood stem cell transplantation after first remission induction treatment in multiple myeloma
Autor: Jl, Harousseau, Attal M, Divine M, Noel Milpied, Marit G, Leblond V, Am, Stoppa, Jh, Bourhis, Caillot D, Boasson M
Publikováno v: Europe PubMed Central
The optimal source of stem cells is a controversial issue in the field of autologous stem cell transplantation. A comparison of autologous bone marrow transplantation (BMT) and peripheral blood stem cell transplantation (PBSCT) after first remission
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::57a9ec6c3c1bac9c2975e16a8a069238
https://pubmed.ncbi.nlm.nih.gov/7581098
Zobrazit plný text záznamu
4
[Prophylactic systemic antibiotherapy with only ceftriaxone in neutropenic patients treated in a protected environment]
Autor: Jl, Harousseau, Noel Milpied, Ae, Reynaud, Derriennic M, Jh, Bourhis, Al, Courtieu
Publikováno v: Europe PubMed Central
Prophylactic systemic antibiotherapy with ceftriaxone (CRO) alone was tested in aplastic patients receiving total gut decontamination and treated in protected environment. To enter the study, the patients had to be afebrile when their polymorphonucle
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::292410c15ddd816911f52a74dde80600
http://europepmc.org/abstract/med/3059275
Zobrazit plný text záznamu
5
[Preventive systemic antibiotherapy with ceftriaxone alone in neutropenic patients treated in a protected environment]
Autor: Jl, Harousseau, Noel Milpied, Ae, Reynaud, Derriennic M, Jh, Bourhis, Al, Courtieu
Publikováno v: Europe PubMed Central
Prophylactic systemic antibiotic therapy with ceftriaxone alone was tested in aplastic patients receiving total gut decontamination and treated in a protected environment. Only patients who were afebrile when their polymorphonuclear (PMN) count fell
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::66b496c6fcd25e2e697376b743f04467
http://europepmc.org/abstract/med/2962087
Zobrazit plný text záznamu
6
[First-line treatment of severe myelomas of the young subject by high-dose melphalan]
Autor: Jl, Harousseau, Milpied N, François Guilhot, Garand R, Jh, Bourhis
Publikováno v: Europe PubMed Central
Six patients (aged 39 to 55 years) with stage III myelomas were treated with IV high dose melphalan (HDM) 140 mg/m2. They had previously received only one or two courses of conventional chemotherapy. The extrahematological tolerance of the procedure
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::8fa48d939619ffd753cc3694686635a7
http://europepmc.org/abstract/med/2971190
Zobrazit plný text záznamu
7
Serum interleukin-12 levels in patients undergoing allogeneic or autologous bone marrow transplantation
Autor: bernard bonnotte, Am, Burdiles, Chehimi J, Carayol G, Pardoux C, Py, Dietrich, Kubin M, Jy, Blay, Caignard A, Ibrahim A, Robinet E, Hayat M, Jl, Pico, Jh, Bourhis, Chouaib S
Publikováno v: ResearcherID
Publons
Europe PubMed Central
Cytokines may be helpful in promoting hematopoietic reconstitution but have also an impact on the cellular interactions that contribute to GvHD and immunologic graft rejection. Because IL-12 is emerging as a central cytokine in immune response, we ha
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::fc2d3782d5879126f04b7dfd98a92a20
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:A1996VJ41900005&KeyUID=WOS:A1996VJ41900005
Zobrazit plný text záznamu
8
[Lethal aplasia after treatment with alpha-interferon of recurrent chronic myeloid leukemia following allogeneic bone marrow graft]
Autor: Jl, Harousseau, Noel Milpied, Jh, Bourhis, Guimbretière L, Talmant P
Publikováno v: Europe PubMed Central
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::4b3ccd31a371a74fcb7dd01cf345345f
http://europepmc.org/abstract/med/2964030
Zobrazit plný text záznamu
9
Akademický článek
Isocitrate dehydrogenase (IDH) 1 and 2 mutations predict better outcome in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: a study of the ALWP of the EBMT.
Autor: Mohty R; Division of Hematology and Oncology and Blood and Marrow Transplantation and Cellular Therapy Program, University of Alabama at Birmingham, Birmingham, AL, USA. rmohty@uabmc.edu.; Service d'Hematologie Clinique, Hopital Saint-Antoine, and INSERM UMRs 938, Paris, France. rmohty@uabmc.edu., Bazarbachi AH; Service d'Hematologie Clinique, Hopital Saint-Antoine, and INSERM UMRs 938, Paris, France.; Division of Hematology/Oncology, Columbia University Irving Medical Center/New York-Presbyterian Hospital, New York, NY, USA., Labopin M; Service d'Hematologie Clinique, Hopital Saint-Antoine, and INSERM UMRs 938, Paris, France.; EBMT Paris Study Office, Saint Antoine Hospital, Paris, France.; Sorbonne University, Paris, France., Esteve J; Institute of Hematology and Oncology, Hospital Clinic Barcelona, Barcelona, Spain., Kröger N; University Hospital Eppendorf, Bone Marrow Transplantation Centre, Hamburg, Germany., Cornelissen JJ; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Hematology, Rotterdam, The Netherlands., Blaise D; Transplantation and Cellular Immunotherapy Program, Department of Hematology, Instititut Paoli Calmettes, MSC Lab, Aix Marseille University, Marseille, France., Socié G; Hopital St. Louis, Dept.of Hematology-BMT, Paris, France., Maury S; Hôpital Henri Mondor, Service d'Hematologie, Creteil, France., Ganser A; Hannover Medical School Department of Haematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover, Germany., Gedde-Dahl T; Oslo University Hospital, Hematology and Institute of Clinical Medicine University of Oslo, Oslo, Norway., von dem Borne P; Dept. of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Bourhis JH; Gustave Roussy Cancer Campus BMT Service, Department of Hematology, Villejuif, France., Bulabois CE; CHU Grenoble Alpes - Université Grenoble Alpes, Service d'Hématologie, Grenoble, France., Yakoub-Agha I; CHU de Lille, Univ Lille, INSERM U1286, Infinite, 59000, Lille, France., Pabst C; Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany., Nguyen S; Universite Paris IV, Hopital la Pitié-Salpêtrière, Hématologie Clinique, Paris, France., Chevallier P; CHU Nantes Dept. D'Hematologie, Nantes, France., Huynh A; Clinical Hematology Unit, Oncopôle, Toulouse, France., Bazarbachi A; Division of Hematology and Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon., Nagler A; Tel Aviv University, BMT and Cord Blood Bank, Chaim Sheba Medical Center, Tel-Hashomer, Israel., Ciceri F; Hematology & Bone Marrow Transplant, IRCCS San Raffaele Scientific Institute, Milan, Italy., Mohty M; Service d'Hematologie Clinique, Hopital Saint-Antoine, and INSERM UMRs 938, Paris, France.; EBMT Paris Study Office, Saint Antoine Hospital, Paris, France.; Sorbonne University, Paris, France.
Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2024 Aug 14. Date of Electronic Publication: 2024 Aug 14.
Zobrazit plný text záznamu
10
Akademický článek
Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms?
Autor: Scheid C; Department I of Medicine, University of Cologne, Cologne, Germany., Eikema DJ; EBMT Statistical Unit, Leiden, The Netherlands., van Gelder M; Maastricht University Medical Center, Maastricht, The Netherlands., Salmenniemi U; Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland., Maertens J; University Hospital Gasthuisberg, Leuven, Belgium., Passweg J; University Hospital, Basel, Switzerland., Blaise D; Institut Paoli Calmettes, Marseille, France., Byrne JL; Nottingham University, Nottingham, United Kingdom., Kröger N; Department for Stem Cell Transplantation, University Medical Center, Hamburg, Germany., Sockel K; Universitätsklinikum Dresden, Dresden, Germany., Chevallier P; CHU Nantes, Nantes, France., Bourhis JH; Gustave Roussy Cancer Campus, Villejuif, France., Cornelissen JJ; Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Sengeloev H; Rigshospitalet, Copenhagen, Denmark., Finke J; University of Freiburg, Freiburg, Germany., Snowden JA; Sheffield Teaching Hospitals NHS Trust, Sheffield, United Kingdom., Gedde-Dahl T; Oslo University Hospital, Rikshospitalet, Oslo, Norway., Cornillon J; Centre Hospitalier Universitaire, Saint Etienne, France., Schanz U; University Hospital, Zurich, Switzerland., Patel A; The Christie NHS Foundation Trust, Manchester, United Kingdom., Koster L; EBMT Data Office, Leiden, The Netherlands., de Wreede LC; Leiden University Medical Center, Leiden, The Netherlands., Hayden P; St. James's Hospital, Dublin, Ireland., Raj K; University College London Hospitals NHS Trust, London, United Kingdom., Drozd-Sokolowska J; Medical University of Warsaw, Warsaw, Poland., Gurnari C; University of Rome Tor Vergata, Rome, Italy., Onida F; Hematology-BMT Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy., McLornan DP; University College London Hospitals NHS Trust, London, United Kingdom., Robin M; Hôpital St-Louis, Paris, France., Yakoub-Agha I; CHU de Lille, University of Lille, INSERM U1286, Infinite, Lille, France.
Publikováno v: Blood [Blood] 2024 Jul 25; Vol. 144 (4), pp. 445-456.
Zobrazit plný text záznamu
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • Další »
  • [22]

Vyhledávací nástroje:

  • RSS
  • Poslat e-mailem

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje
Pouze tištěné dokumenty
Zahrnout EIZ
  • 210 Akademické články
  • 84 hematopoietic stem cell transplantation
  • 44 leukemia, myeloid, acute
  • 28 bone marrow transplantation
  • 28 graft vs host disease
  • 23 multiple myeloma
  • 22 antineoplastic combined chemotherapy protocols
  • 20 transplantation conditioning
  • 16 myelodysplastic syndromes
  • 13 precursor cell lymphoblastic leukemia-lymphoma
  • 11 stem cell transplantation
  • 10 hematologic neoplasms
  • 10 killer cells, natural
  • 9 leukemia, myelogenous, chronic, bcr-abl positive
  • 9 leukemia, myeloid
  • 9 peripheral blood stem cell transplantation
  • 8 lymphoma, non-hodgkin
  • 8 salvage therapy
  • 7 antigens, cd34
  • 7 antineoplastic agents
  • 7 leukemia
  • 7 neutropenia
  • 6 adult
  • 6 cytomegalovirus infections
  • 6 hematopoietic stem cells
  • 6 humans
  • 6 tissue donors
  • 5 antilymphocyte serum
  • 5 cytotoxicity, immunologic
  • 5 granulocyte colony-stimulating factor
  • 5 hematopoietic stem cell mobilization
  • 5 hepatic veno-occlusive disease
  • 5 middle aged
  • 5 transplantation, homologous
  • 4 agranulocytosis
  • 4 bacterial infections
  • 4 bone marrow
  • 4 ceftriaxone
  • 4 chromosome aberrations
  • 4 cord blood stem cell transplantation
  • 4 fusion proteins, bcr-abl
  • 4 hodgkin disease
  • 4 immunosuppressive agents
  • 4 lymphocyte transfusion
  • 4 neoplasms
  • 4 neoplasms, second primary
  • 4 pyrimidines
  • 4 whole-body irradiation
  • 3 adolescent
  • 3 anemia, aplastic
  • 3 antibodies, monoclonal
  • 46 nature publishing group
  • 33 elsevier
  • 18 wiley-blackwell
  • 13 ferrata storti foundation
  • 12 nature publishing group, specialist journals
  • 11 taylor & francis
  • 7 american society of clinical oncology
  • 6 oxford university press
  • 5 american society of hematology
  • 5 carden jennings publishing
  • 4 elsevier masson
  • 3 blackwell
  • 3 elsevier science ltd
  • 3 lippincott williams & wilkins
  • 3 springer verlag
  • 3 springer-verlag france
  • 2 american association of immunologists
  • 2 blackwell scientific publications
  • 2 elsevier inc
  • 2 elsevier science inc
  • 2 frontiers research foundation]
  • 2 impact journals
  • 2 masson
  • 2 wolters kluwer health, inc
  • 1 american association for cancer research
  • 1 american society for microbiology
  • 1 biomed central
  • 1 blackwell science
  • 1 elsevier health science
  • 1 elsevier/north-holland
  • 1 elsevier-masson sas
  • 1 john libbey eurotext ltd
  • 1 john wiley & sons ltd
  • 1 karger
  • 1 microbiology society
  • 1 national center for infectious diseases, centers for disease control and prevention (cdc)
  • 1 nature publishing group on behalf of cancer research uk
  • 1 pergamon press
  • 1 public library of science
  • 1 published by oxford university press on behalf of the infectious diseases society of america
  • 1 radiological society of north america
  • 1 the association
  • 1 wiley
  • 1 wiley blackwell
  • 1 wiley-vch
  • 44 bone marrow transplantation
  • 21 blood
  • 13 haematologica
  • 12 leukemia
  • 9 american journal of hematology
  • 9 british journal of haematology
  • 8 leukemia lymphoma
  • 7 bulletin du cancer
  • 7 journal of clinical oncology official journal of the american society of clinical oncology
  • 5 biology of blood and marrow transplantation journal of the american society for blood and marrow transplantation
  • 3 blood advances
  • 3 clinical infectious diseases an official publication of the infectious diseases society of america
  • 3 european journal of cancer oxford england 1990
  • 3 european journal of haematology
  • 3 hematology and cell therapy
  • 3 presse medicale paris france 1983
  • 2 annals of hematology
  • 2 clinical lymphoma myeloma leukemia
  • 2 experimental hematology
  • 2 frontiers in immunology
  • 2 hemasphere
  • 2 journal of immunology baltimore md 1950
  • 2 oncogene
  • 2 oncoimmunology
  • 2 oncotarget
  • 2 pathologie biologie
  • 2 transplantation and cellular therapy
  • 1 annales de dermatologie et de venereologie
  • 1 annales de linstitut pasteur immunology
  • 1 biochemical and biophysical research communications
  • 1 british journal of cancer
  • 1 british journal of dermatology
  • 1 cancer
  • 1 cancer genetics and cytogenetics
  • 1 cancer medicine
  • 1 cancer radiotherapie journal de la societe francaise de radiotherapie oncologique
  • 1 cancer research
  • 1 clinical cancer research an official journal of the american association for cancer research
  • 1 current research in translational medicine
  • 1 emerging infectious diseases
  • 1 european cytokine network
  • 1 european journal of immunology
  • 1 expert review of clinical immunology
  • 1 fundamental clinical pharmacology
  • 1 gastroenterologie clinique et biologique
  • 1 hematology journal the official journal of the european haematology association
  • 1 hematology oncology clinics of north america
  • 1 immunology
  • 1 journal of clinical microbiology
  • 1 journal of hematology oncology
  • 210 MEDLINE
  • 8 OpenAIRE
  • 9 france
  • 6 europe
  • 1 algeria
  • 1 belgium
  • 1 united states

Možnosti vyhledávání

  • Tematická mapa
  • Historie vyhledávání
  • Pokročilé vyhledávání

Objevte více

  • Abecední procházení

Hledáte pomoc?

  • Tipy pro vyhledávání
načítá se......